Sequana Medical NV (EBR:SEQUA)
Belgium · Delayed Price · Currency is EUR 1.376
+0.016 (1.18%)
Aug 1, 2025, 5:35 PM CET
Sequana Medical NV Company Description
Sequana Medical NV develops and commercializes treatments for patients with diuretic-resistant fluid overload in liver disease, cancer, and heart failure in Belgium, Germany, France, and internationally.
The company offers alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; and Direct Sodium Removal (DSR) for the treatment of fluid overload spread across the body.
Sequana Medical NV was founded in 2006 and is headquartered in Gent, Belgium.
Sequana Medical NV
| Country | Belgium |
| Founded | 2006 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 48 |
| CEO | Ian Crosbie |
Contact Details
Address: Kortrijksesteenweg 1112 Gent, 9051 Belgium | |
| Phone | 32 9 292 8065 |
| Website | sequanamedical.com |
Stock Details
| Ticker Symbol | SEQUA |
| Exchange | Euronext Brussels |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | BE0974340722 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Ian Crosbie | Chief Executive Officer and Executive Director |
| Kirsten Van Bockstaele | Chief Financial Officer |
| Dr. Gijs Klarenbeek M.D. | MD and Chief Medical Officer |
| Martijn Blom | Chief Commercial Officer |